International Journal of Pharmaceutical Investigation, 2021, 11, 1, 123-126.
DOI: 10.5530/ijpi.2021.1.23
Published: April 2021
Type: Original Article
Authors:
Abdullah Khaloofah Alahmari
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Ziyad Saeed Almalki
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Muhammad Shahid Iqbal
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Manal Abdullah Alossaimi
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, SAUDI ARABIA
Mohammed Zaid Alsaber
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Raslan Abdullah Alanazi
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Yazeed Mohammed Alruwaili
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Saad Nashmi Altheiby
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Thekra Omar Bin Salman
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
ABSTRACT
Objectives: This study determined knowledge and attitude of pharmacists about biosimilar mdications in Saudi Arabia. Methods: Pharmacists from different areas and regions were approached to participate in this cross-sectional study. Data were collected by a pre-validated and selfadministered research tool using a convenience sampling technique. Analyses and interpretation of the data were done using descriptive and inferential statistics with Statistical Package for Social Sciences (SPSS) version 24.0. Results: A total of 319 pharmacists from different specialties participated in the study. A total of 111 pharmacists were males, and 208 were females. All of the pharmacists had varied expertise. Around 41.4% of the studied pharmacists were practicing in the community, 34.5% in hospitals and 24.1% were in other areas. Conclusion: This study reported the current level of pharmacists’ knowledge and attitude about biosimilar medications in Saudi Arabia. Statistically, a significant association was observed between male and female pharmacists regarding the introduction of biosimilar medications in the Saudi Arabian healthcare setup.
Keywords: Pharmacists, Biosimilar medications, Knowledge, Attitude, Saudi Arabia.